Comparing cancer detection rates of patients undergoing short term follow-up vs routine follow-up after benign breast biopsies, is follow-up needed?

被引:5
作者
Plecha, Donna M. [1 ]
Garlick, Courtney [2 ]
Dubchuck, Christina [1 ]
Thompson, Cheryl [3 ]
Constantinou, Niki [1 ]
机构
[1] Univ Hosp, Dept Radiol, Case Med Ctr, Mather Pavil,B402,11100 Euclid Ave, Cleveland, OH 44106 USA
[2] Mercy Hlth, 1500 E Sherman Blvd, Muskegon, MI 49444 USA
[3] Case Western Reserve Univ, Dept Family Med & Community Hlth, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
关键词
Benign concordant breast biopsy; Stereotactic ultrasound MRI breast biopsy; NATIONAL ACCREDITATION PROGRAM; CORE-NEEDLE; GUIDED BIOPSY; LESIONS; CONCORDANT; MRI; DIAGNOSIS; RECOMMENDATIONS; EXPERIENCE; CENTERS;
D O I
10.1016/j.clinimag.2016.11.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare cancer rates after benign breast biopsies between patients with short term imaging followup (STFU) and those with routine follow-up (RFU). Materials & methods: Retrospective review of benign stereotactic, US or DCE-MRI breast biopsies. Results: Of580 lesions, 192 (33%) had STFU, and 388 (67%) had RFU. For US and mammographic detected lesions," there is no difference in cancer rates between the STFU (1 cancer, n = 148) and the RFU group (0 cancer, n = 365) (p = 0.29). There were 2 cancers in the STFU group versus 0 in the RFU DCE-MRI group (p = 0.54). Conclusion: Our results support RFU after benign ultrasound and stereotactic breast biopsies. (C) 2016 Elsevier Inc All rights reserved.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 28 条
[1]   Surgical Leadership and Standardization of Multidisciplinary Breast Cancer Care The Evolution of the National Accreditation Program for Breast Centers [J].
Bensenhaver, Jessica ;
Winchester, David P. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (03) :609-+
[2]  
Bevers Therese B, 2006, J Natl Compr Canc Netw, V4, P480
[3]   Percutaneous core biopsy of the breast: Effect of operator experience and number of samples on diagnostic accuracy [J].
Brenner, RJ ;
Fajardo, L ;
Fisher, PR ;
Dershaw, DD ;
Evans, WP ;
Bassett, L ;
Feig, S ;
Mendelson, E ;
Jackson, V ;
Margolin, FR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 166 (02) :341-346
[4]   Systematic Review: Comparative Effectiveness of Core-Needle and Open Surgical Biopsy to Diagnose Breast Lesions [J].
Bruening, Wendy ;
Fontanarosa, Joann ;
Tipton, Kelley ;
Treadwell, Jonathan R. ;
Launders, Jason ;
Schoelles, Karen .
ANNALS OF INTERNAL MEDICINE, 2010, 152 (04) :238-U75
[5]   Patient perceptions of breast biopsy procedures for screen-detected lesions [J].
Geller, BM ;
Oppenheimer, RG ;
Mickey, RM ;
Worden, JK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :1063-1069
[6]   Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up [J].
Jackman, RJ ;
Nowels, KW ;
Rodriguez-Soto, J ;
Marzoni, FA ;
Finkelstein, SI ;
Shepard, MJ .
RADIOLOGY, 1999, 210 (03) :799-805
[7]   Breast Cancer Detection with Short-Interval Follow-up Compared with Return to Annual Screening in Patients with Benign Stereotactic or US-guided Breast Biopsy Results [J].
Johnson, Jason M. ;
Johnson, Alisa K. ;
O'Meara, Ellen S. ;
Miglioretti, Diana L. ;
Geller, Berta M. ;
Hotaling, Elise N. ;
Herschorn, Sally D. .
RADIOLOGY, 2015, 275 (01) :54-60
[8]  
Kaufman, 2014, METHODS ANOPHELES RE, P419
[9]   Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection-A Novel Approach to Breast Cancer Screening With MRI [J].
Kuhl, Christiane K. ;
Schrading, Simone ;
Strobel, Kevin ;
Schild, Hans H. ;
Hilgers, Ralf-Dieter ;
Bieling, Heribert B. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (22) :2304-U176
[10]   MRI Follow-Up After Concordant, Histologically Benign Diagnosis of Breast Lesions Sampled by MRI-Guided Biopsy [J].
Li, Jie ;
Dershaw, D. David ;
Lee, Carol H. ;
Kaplan, Jennifer ;
Morris, Elizabeth A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (03) :850-855